.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Deloitte
Medtronic
UBS
Johnson and Johnson
Queensland Health
QuintilesIMS
Chubb
Cipla
McKinsey

Generated: September 21, 2017

DrugPatentWatch Database Preview

PROMETHAZINE DM Drug Profile

« Back to Dashboard

What is the patent landscape for Promethazine Dm, and when can generic versions of Promethazine Dm launch?

Promethazine Dm is a drug marketed by Vintage and is included in one NDA.

The generic ingredient in PROMETHAZINE DM is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.

Summary for Tradename: PROMETHAZINE DM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list8
Clinical Trials: see list39
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROMETHAZINE DM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage
PROMETHAZINE DM
dextromethorphan hydrobromide; promethazine hydrochloride
SYRUP;ORAL040649-001Feb 14, 2006AARXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Chubb
Express Scripts
Cerilliant
US Department of Justice
Federal Trade Commission
US Army
Julphar
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot